Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Clinical Trials

At any one time the University of Oxford sponsors around 1,000 academic designed and led clinical research studies within the EU of which about 150 are interventional trials ranging from phase I to phase IV. The University sponsors approximately 350 further studies outside the EU, largely through its Centre for Tropical Medicine and Global Health.

Often in partnership with Oxford University Hospitals Foundation NHS Trust or Oxford Health Foundation NHS Trust most of the EU-based studies are run by one of the University’s six UKCRC fully registered specialist clinical trials units:

  • Diabetes Trials Unit national and multinational trials of the management and treatment of diabetes;
  • Oxford Clinical Trials Research Unit which integrates the following trials groups:
  • Centre for Statistics in Medicine
  • Critical Care, Trauma and Rehabilitation Trials Group
  • Gastroenterology Trials Group
  • Oncology Clinical Trials Office  (all phases)
  • Respiratory Trials Unit
  • Rheumatology
  • Surgical Intervention Trials Unit

Clinical Trials News

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

World’s largest clinical trial for COVID-19 treatments expands internationally

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.

World Health Organization lists Oxford coronavirus vaccine for emergency use

The Oxford / AstraZeneca vaccine has today been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of age and older, including those over 65.